NICE Expands Access to Continuous Glucose Monitoring for Adults with Type 2 Diabetes
NICE has recommended wider access to continuous glucose monitoring (CGM) for adults with type 2 diabetes, particularly those receiving insulin therapy, in its 2022 guidance. The recommendations call for offering…